Design and synthesis of potent, non-peptide inhibitors of HCV NS3 protease
X Zhang, AC Schmitt, W Jiang, Z Wasserman…
Index: Zhang, Xiaojun; Schmitt, Aaron C.; Jiang, Wen; Wasserman, Zelda; Decicco, Carl P. Bioorganic and Medicinal Chemistry Letters, 2003 , vol. 13, # 6 p. 1157 - 1160
Full Text: HTML
Citation Number: 38
Abstract
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease leading to cirrhosis, hepatocellular carcinoma or liver failure. 1 Current therapies involve treatment with interferon-α, either alone or in combination with ribavirin; however, poor efficacy and severe side effects are frequent. 2 There is thus an urgent need to discover inhibitors of HCV-specific proteins for the development of anti-HCV drugs. One of the most intensively studied and ...
Related Articles:
C-Clycosylation of cyclic N-acyliminium ions with trimethylsilyloxyfuran
[Pichon, Marianne; Figadere, Bruno; Cave, Andre Tetrahedron Letters, 1996 , vol. 37, # 44 p. 7963 - 7966]
Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modifications
[St-Denis, Yves; Augelli-Szafran, Corinne E.; Bachand, Benoit; Berryman, Kent A.; DiMaio, John; Doherty, Annette M.; Edmunds, Jeremy J.; Leblond, Lorraine; Levesque, Sophie; Narasimhan, Lakshmi S.; Penvose-Yi, Jan R.; Rubin, J. Ronald; Tarazi, Micheline; Winocour, Peter D.; Siddiqui, M. Arshad Bioorganic and Medicinal Chemistry Letters, 1998 , vol. 8, # 22 p. 3193 - 3198]